Skyrizi is used to treat autoimmune and inflammatory conditions like Crohn’s disease and plaque psoriasis. It is administered via intravenous injection by a healthcare professional or subcutaneous ...
Please provide your email address to receive an email when new articles are posted on . The FDA is considering a 500 mg subcutaneous initiation dose. Weekly 500 mg autoinjector and biweekly 10 mg/kg ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results